Retired Partner
Peter Wald retired from the partnership in December 2023. He has been one of the country’s most sought after, influential, and successful trial lawyers. He has an outstanding record of winning “bet the company” cases for US and international clients in federal and state courts across the country. His cases have been routinely featured in the national press. From 2004-2011, Peter served as Global Chair of Latham & Watkins’ Litigation & Trial Department. In 2015, he was named a Securities MVP by Law360 for his ground-breaking work on behalf of Allergan in successfully resisting a hostile takeover attempt by Valeant Pharmaceuticals and Pershing Square Capital Management.
Latham litigators recognized for securing a complete appellate victory at the Delaware Supreme Court in a stockholder derivative suit challenging Oracle’s US$9.4 billion acquisition of NetSuite.
Four Latham teams were honored as winners of The American Lawyer’s prestigious Litigators of the Week column in 2023. The wins spanned multiple litigation practices and industries, including antitrust, intellectual property, securities, environmental and product liability, technology, and sports, among others.
Latham Litigators recognized for their representation of clients Toptal and NextGen Healthcare.